Osteopetrosis

16 registered clinical trials studyying Osteopetrosis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Outcomes of Patients With Osteopetrosis Weight-bearing Bone Fractures NCT06521580	Kasr El Aini Hospital	N/A
Completed	ACTIMMUNE in Intermediate Osteopetrosis NCT02666768	Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	Phase 2
Terminated	Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant NCT02065869	Bellicum Pharmaceuticals	Phase 1 / Phase 2
Active Not Recruiting	Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant NCT03301168	Bellicum Pharmaceuticals	Phase 1 / Phase 2
Recruiting	Longitudinal Study of Neurodegenerative Disorders NCT03333200	University of Pittsburgh	—
Unknown	Hematopoietic Stem Cell Transplantation for Malignant Infantile Osteopetrosis NCT01087398	Tehran University of Medical Sciences	Phase 2 / Phase 3
Terminated	T-cell Depleted Alternative Donor Transplantation NCT00968864	Wake Forest University Health Sciences	Phase 2
Completed	Clinical Assessment of Patients With High Bone Mass Due to Mutation in Lrp5 NCT01199094	Odense University Hospital	—
Completed	Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells NCT00730314	Children's Hospital Los Angeles	Phase 1 / Phase 2
Terminated	Reduced Intensity AlloTransplant For Osteopetrosis NCT00638820	Masonic Cancer Center, University of Minnesota	Phase 2
Terminated	Stem Cell Transplantation for Children Affected With Osteopetrosis NCT00145587	St. Jude Children's Research Hospital	N/A
Terminated	rhPTH Therapy for Low Turnover Bone Fragility NCT00145886	University of Chicago	Phase 1
Completed	Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Dis NCT01019876	Columbia University	Phase 2 / Phase 3
Completed	Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis NCT00043329	InterMune	—
Completed	Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis NCT00004402	FDA Office of Orphan Products Development	Phase 3
No Longer Available	Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Trans NCT01200017	Christopher Dvorak	—